| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000040340 |
| Receipt No. | R000046033 |
| Scientific Title | Exploratory study to identify salivary biomarkers reflecting temporal disease activity in patients with Crohn's disease |
| Date of disclosure of the study information | 2021/07/01 |
| Last modified on | 2020/05/08 (Ver. 2) |
| Basic information | ||
| Public title | Exploratory study to identify salivary biomarkers reflecting temporal disease activity in patients with Crohn's disease | |
| Acronym | Exploratory study to identify salivary biomarkers reflecting temporal disease activity in patients with Crohn's disease | |
| Scientific Title | Exploratory study to identify salivary biomarkers reflecting temporal disease activity in patients with Crohn's disease | |
| Scientific Title:Acronym | Exploratory study to identify salivary biomarkers reflecting temporal disease activity in patients with Crohn's disease | |
| Region |
|
|
| Condition | ||
| Condition | Crohn's disease | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | We will search for salivary biomarkers that reflect the disease activity of Crohn's disease by obtaining saliva, blood and serum of Crohn's disease patients and healthy subjects over time for statistical analysis of their correlations. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Evaluation of disease activity of Crohn's disease by saliva test
The saliva test and the CDAI score will be tracked longitudinally to evaluate the correlation of each. By using blood tests together, biomarkers of inflammation that can be reflected in saliva tests will be searched. In addition, the specificity of saliva test reflecting the disease activity of Crohn's disease is also evaluated by setting control group having no systemic disease.. |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Intra-oral condition
Patients who meet both the following criteria for caries and periodontal disease: Caries: Having experienced caries treatment and having at least one tooth restoration due to caries. It does not matter whether it is an untreated tooth at the time of registration Periodontal disease: Patients who have a periodontal pocket of 4 mm or more at one or more places in the periodontal examination. Crohn's disease patients Patients who have been diagnosed with Crohn's disease of both small and large intestine at the Department of Gastroenterology, Tohoku University Hospital and who regularly visit the hospital and who have been diagnosed with the above oral conditions by the Department of Conservative Dentistry. Health patients Patients who have visited the Tohoku University Hospital Department of Conservative Dentistry and have been diagnosed with the above oral conditions and have no systemic disease. |
|||
| Key exclusion criteria | Patients using colostomy.
If it seems difficult to comply with protocol treatment due to medical or psychological abnormalities. the doctor in charge determines that it is inappropriate. |
|||
| Target sample size | 20 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Tohoku University Graduate School of Dentistry | ||||||
| Division name | Division of Operative Dentistry | ||||||
| Zip code | 980-8575 | ||||||
| Address | 4-1, Seiryo-machi, Aoba, Sendai 980-8575, Miyagi | ||||||
| TEL | 022-717-8343 | ||||||
| mssaito@dent.tohoku.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Tohoku University Graduate School of Dentistry | ||||||
| Division name | Division of Operative Dentistry | ||||||
| Zip code | 980-8575 | ||||||
| Address | 4-1, Seiryo-machi, Aoba, Sendai 980-8575, Miyagi | ||||||
| TEL | 022-717-8343 | ||||||
| Homepage URL | |||||||
| yahataendo@tohoku.ac.jp | |||||||
| Sponsor | |
| Institute | Tohoku University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Fiber Medicine Co., Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Ethical committee of Tohoku University Graduate School of Dentistry |
| Address | 4-1, Seiryo-machi, Aoba, Sendai 980-8575, Miyagi |
| Tel | 022-717-8244 |
| den-syom@grp.tohoku.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB | |||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | Evaluation of disease activity of Crohn's disease by saliva test
The saliva test value and the CDAI score will be tracked longitudinally to evaluate the correlation of each. By using blood tests together, salivary biomarkers reflecting inflammation status will be identified. In addition, the specificity of saliva test for reflecting the disease activity of Crohn's disease is also evaluated by setting control group having no systemic disease. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046033 |